These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 16020101)

  • 1. Etoposide, cisplatin, epirubicin chemotherapy in the treatment of pediatric liver tumors.
    Casanova M; Massimino M; Ferrari A; Spreafico F; Piva L; Coppa J; Luksch R; Cefalo G; Terenziani M; Polastri D; Bellani FF; Mazzaferro V
    Pediatr Hematol Oncol; 2005; 22(3):189-98. PubMed ID: 16020101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B; Bode U; von Schweinitz D
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatic arterial infusion chemotherapy for hepatocellular carcinoma by EEP regimen].
    Takayasu Y
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():624-8. PubMed ID: 11762024
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94.
    Fuchs J; Bode U; von Schweinitz D; Weinel P; Erttmann R; Harms D; Mildenberger H
    Klin Padiatr; 1999; 211(4):305-9. PubMed ID: 10472567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.
    Zsíros J; Maibach R; Shafford E; Brugieres L; Brock P; Czauderna P; Roebuck D; Childs M; Zimmermann A; Laithier V; Otte JB; de Camargo B; MacKinlay G; Scopinaro M; Aronson D; Plaschkes J; Perilongo G
    J Clin Oncol; 2010 May; 28(15):2584-90. PubMed ID: 20406943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrolamellar hepatocellular carcinoma in children and adolescents.
    Katzenstein HM; Krailo MD; Malogolowkin MH; Ortega JA; Qu W; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Newman K; Finegold MJ; Haas JE; Sensel MG; Castleberry RP; Bowman LC
    Cancer; 2003 Apr; 97(8):2006-12. PubMed ID: 12673731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical resection and chemotherapy improve survival rate for patients with hepatoblastoma.
    Carceller A; Blanchard H; Champagne J; St-Vil D; Bensoussan AL
    J Pediatr Surg; 2001 May; 36(5):755-9. PubMed ID: 11329582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of epirubicin and etoposide combination chemotherapy in advanced hepatocellular carcinoma: a retrospective analysis.
    Lee JL; Ryu MH; Chang HM; Kim TW; Lee SS; Sym SJ; Kim MK; Kim KM; Lee JS; Kang YK
    J Gastroenterol Hepatol; 2008 May; 23(5):811-6. PubMed ID: 17995941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of the HB-89 Study in treatment of malignant epithelial liver tumors in childhood and concept of a new HB-94 protocol].
    von Schweinitz D; Bürger D; Bode U; Weinel P; Erttmann R; Hecker H; Mildenberger H
    Klin Padiatr; 1994; 206(4):282-8. PubMed ID: 7526028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case with hepatocellular carcinoma effectively treated by continuous hepatic arterial infusion of etoposide, epirubicin and CDDP].
    Tarusawa K; Yodono H; Ikami I; Sasaki T; Kanehira J; Takahashi S; Shibutani K; Noda H; Shinohara A; Takekawa D
    Gan To Kagaku Ryoho; 1992 Mar; 19(3):383-6. PubMed ID: 1311915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of malignant liver tumors in childhood. An intermediate report of the HB-89 multicenter study of the GPOH].
    von Schweinitz D; Bürger D; Weinel P; Mildenberger H
    Klin Padiatr; 1992; 204(4):214-20. PubMed ID: 1381454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult type vs. Childhood hepatocellular carcinoma--are they the same or different lesions? Biology, natural history, prognosis, and treatment.
    Czauderna P
    Med Pediatr Oncol; 2002 Nov; 39(5):519-23. PubMed ID: 12228910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ Sharing (UNOS) database.
    Austin MT; Leys CM; Feurer ID; Lovvorn HN; O'Neill JA; Pinson CW; Pietsch JB
    J Pediatr Surg; 2006 Jan; 41(1):182-6. PubMed ID: 16410130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.
    Malogolowkin MH; Katzenstein H; Krailo MD; Chen Z; Bowman L; Reynolds M; Finegold M; Greffe B; Rowland J; Newman K; Womer RB; London WB; Castleberry RP
    J Clin Oncol; 2006 Jun; 24(18):2879-84. PubMed ID: 16782927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatic arterial infusion chemotherapy using totally implantable port system].
    Takayasu Y; Yamamoto S; Ikeda J
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1516-20. PubMed ID: 11015995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen).
    Boucher E; Corbinais S; Brissot P; Boudjema K; Raoul JL
    Cancer Chemother Pharmacol; 2002 Oct; 50(4):305-8. PubMed ID: 12357305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience.
    Weeda VB; Murawski M; McCabe AJ; Maibach R; Brugières L; Roebuck D; Fabre M; Zimmermann A; Otte JB; Sullivan M; Perilongo G; Childs M; Brock P; Zsíros J; Plaschkes J; Czauderna P; Aronson DC
    Eur J Cancer; 2013 Aug; 49(12):2698-704. PubMed ID: 23683550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.
    Perilongo G; Maibach R; Shafford E; Brugieres L; Brock P; Morland B; de Camargo B; Zsiros J; Roebuck D; Zimmermann A; Aronson D; Childs M; Widing E; Laithier V; Plaschkes J; Pritchard J; Scopinaro M; MacKinlay G; Czauderna P
    N Engl J Med; 2009 Oct; 361(17):1662-70. PubMed ID: 19846851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination therapy with transarterial chemo-lipiodolization and systemic chemo-infusion for large extensive hepatocellular carcinoma invading portal vein in comparison with conservative management.
    Jang JW; Bae SH; Choi JY; Oh HJ; Kim MS; Lee SY; Kim CW; Chang UI; Nam SW; Cha SB; Lee YJ; Chun HJ; Choi BG; Byun JY; Yoon SK
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):9-15. PubMed ID: 16614848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical observation on the treatment outcome of 14 children with hepatoblastoma in a single medical center].
    Pan C; Tang JY; Chen J; Xue HL; Dong L; Zhou M; Jiang H; Ye QD; Gu LJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Aug; 11(8):659-62. PubMed ID: 19695195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.